ReP USP - Resultado da busca

Artigo de periodico
Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis (2019)
Silva, M. G; Shinjo, Sueli Mieko Oba ; Marie, Suely Kazue Nagahashi ; Shinjo, Samuel Katsuyuki
Fonte: Clinical and experimental rheumatology. Unidade: FM
Assuntos: INTERLEUCINAS, MIOSITE, DERMATOPATIAS, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, M. G et al. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis. Clinical and experimental rheumatology, v. 37, n. 4, p. 656-662, 2019Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/33118. Acesso em: 03 jul. 2024.
APA
Silva, M. G., Shinjo, S. M. O., Marie, S. K. N., & Shinjo, S. K. (2019). Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis. Clinical and experimental rheumatology, 37( 4), 656-662. Recuperado de http://observatorio.fm.usp.br/handle/OPI/33118
NLM
Silva MG, Shinjo SMO, Marie SKN, Shinjo SK. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis [Internet]. Clinical and experimental rheumatology. 2019 ; 37( 4): 656-662.[citado 2024 jul. 03 ] Available from: http://observatorio.fm.usp.br/handle/OPI/33118
Vancouver
Silva MG, Shinjo SMO, Marie SKN, Shinjo SK. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis [Internet]. Clinical and experimental rheumatology. 2019 ; 37( 4): 656-662.[citado 2024 jul. 03 ] Available from: http://observatorio.fm.usp.br/handle/OPI/33118
Artigo de periodico
Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies (2019)
Borges, Isabela Bruna Pires; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: ESTATINAS, DISLIPIDEMIAS, MIOSITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Isabela Bruna Pires e SHINJO, Samuel Katsuyuki. Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies. Rheumatology international, v. 39, n. 2, p. 311-316, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00296-018-4215-x. Acesso em: 03 jul. 2024.
APA
Borges, I. B. P., & Shinjo, S. K. (2019). Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies. Rheumatology international, 39( 2), 311-316. doi:10.1007/s00296-018-4215-x
NLM
Borges IBP, Shinjo SK. Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies [Internet]. Rheumatology international. 2019 ; 39( 2): 311-316.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s00296-018-4215-x
Vancouver
Borges IBP, Shinjo SK. Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies [Internet]. Rheumatology international. 2019 ; 39( 2): 311-316.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s00296-018-4215-x
Artigo de periodico
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies (2018)
Souza, Fernando Henrique Carlos de; Miossi, Renata; Moraes, Julio Cesar Bertacini de; Bonfá, Eloísa Silva Dutra de Oliveira; Shinjo, Samuel Katsuyuki
Fonte: Advances in rheumatology. Unidade: FM
Assuntos: MIOSITE, ANTICORPOS MONOCLONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Fernando Henrique Carlos de et al. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies. Advances in rheumatology, v. 58, 2018Tradução . . Disponível em: https://doi.org/10.1186/s42358-018-0030-z. Acesso em: 03 jul. 2024.
APA
Souza, F. H. C. de, Miossi, R., Moraes, J. C. B. de, Bonfá, E. S. D. de O., & Shinjo, S. K. (2018). Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies. Advances in rheumatology, 58. doi:10.1186/s42358-018-0030-z
NLM
Souza FHC de, Miossi R, Moraes JCB de, Bonfá ESD de O, Shinjo SK. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 jul. 03 ] Available from: https://doi.org/10.1186/s42358-018-0030-z
Vancouver
Souza FHC de, Miossi R, Moraes JCB de, Bonfá ESD de O, Shinjo SK. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 jul. 03 ] Available from: https://doi.org/10.1186/s42358-018-0030-z
Artigo de periodico
Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review (2018)
Borges, Isabela Bruna Pires; Silva, Marilda Guimares; Misse, Rafael Giovane; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: ESTUDOS RETROSPECTIVOS, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Isabela Bruna Pires et al. Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review. Rheumatology international, v. 38, n. 2, p. 293-301, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00296-017-3821-3. Acesso em: 03 jul. 2024.
APA
Borges, I. B. P., Silva, M. G., Misse, R. G., & Shinjo, S. K. (2018). Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review. Rheumatology international, 38( 2), 293-301. doi:10.1007/s00296-017-3821-3
NLM
Borges IBP, Silva MG, Misse RG, Shinjo SK. Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review [Internet]. Rheumatology international. 2018 ; 38( 2): 293-301.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s00296-017-3821-3
Vancouver
Borges IBP, Silva MG, Misse RG, Shinjo SK. Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review [Internet]. Rheumatology international. 2018 ; 38( 2): 293-301.[citado 2024 jul. 03 ] Available from: https://doi.org/10.1007/s00296-017-3821-3
Artigo de periodico
Physical exercise among patients with systemic autoimmune myopathies (2018)
Oliveira, Diego Sales de; Misse, Rafael Giovani; Lima, Fernanda Rodrigues; Shinjo, Samuel Katsuyuki
Fonte: Advances in rheumatology. Unidade: FM
Assuntos: EXERCÍCIO FÍSICO, MIOSITE, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Diego Sales de et al. Physical exercise among patients with systemic autoimmune myopathies. Advances in rheumatology, v. 58, 2018Tradução . . Disponível em: https://doi.org/10.1186/s42358-018-0004-1. Acesso em: 03 jul. 2024.
APA
Oliveira, D. S. de, Misse, R. G., Lima, F. R., & Shinjo, S. K. (2018). Physical exercise among patients with systemic autoimmune myopathies. Advances in rheumatology, 58. doi:10.1186/s42358-018-0004-1
NLM
Oliveira DS de, Misse RG, Lima FR, Shinjo SK. Physical exercise among patients with systemic autoimmune myopathies [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 jul. 03 ] Available from: https://doi.org/10.1186/s42358-018-0004-1
Vancouver
Oliveira DS de, Misse RG, Lima FR, Shinjo SK. Physical exercise among patients with systemic autoimmune myopathies [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 jul. 03 ] Available from: https://doi.org/10.1186/s42358-018-0004-1
Artigo de periodico
High prevalence of metabolic syndrome in antisynthetase syndrome (2018)
Araujo, P. A. O.; Silva, M. G.; Borba Neto, Eduardo Ferreira; Shinjo, Sueli Mieko Oba
Fonte: Clinical and experimental rheumatology. Unidade: FM
Assuntos: ADIPOSIDADE, SÍNDROME X METABÓLICA, FATORES DE RISCO, ESTUDOS DE COORTES, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, P. A. O. et al. High prevalence of metabolic syndrome in antisynthetase syndrome. Clinical and experimental rheumatology, v. 36, n. 2, p. 241-247, 2018Tradução . . Acesso em: 03 jul. 2024.
APA
Araujo, P. A. O., Silva, M. G., Borba Neto, E. F., & Shinjo, S. M. O. (2018). High prevalence of metabolic syndrome in antisynthetase syndrome. Clinical and experimental rheumatology, 36( 2), 241-247.
NLM
Araujo PAO, Silva MG, Borba Neto EF, Shinjo SMO. High prevalence of metabolic syndrome in antisynthetase syndrome. Clinical and experimental rheumatology. 2018 ; 36( 2): 241-247.[citado 2024 jul. 03 ]
Vancouver
Araujo PAO, Silva MG, Borba Neto EF, Shinjo SMO. High prevalence of metabolic syndrome in antisynthetase syndrome. Clinical and experimental rheumatology. 2018 ; 36( 2): 241-247.[citado 2024 jul. 03 ]
Artigo de periodico
Relevance of serum angiogenic cytokines in adult patients with dermatomyositis (2018)
Silva, Thiago Costa Pamplona da; SILVA, Marilda Guimaraes; Shinjo, Samuel Katsuyuki
Fonte: Advances in rheumatology. Unidade: FM
Assuntos: CITOCINAS, MIOSITE, NEOVASCULARIZAÇÃO PATOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Thiago Costa Pamplona da e SILVA, Marilda Guimaraes e SHINJO, Samuel Katsuyuki. Relevance of serum angiogenic cytokines in adult patients with dermatomyositis. Advances in rheumatology, v. 58, 2018Tradução . . Disponível em: https://doi.org/10.1186/s42358-018-0018-8. Acesso em: 03 jul. 2024.
APA
Silva, T. C. P. da, SILVA, M. G., & Shinjo, S. K. (2018). Relevance of serum angiogenic cytokines in adult patients with dermatomyositis. Advances in rheumatology, 58. doi:10.1186/s42358-018-0018-8
NLM
Silva TCP da, SILVA MG, Shinjo SK. Relevance of serum angiogenic cytokines in adult patients with dermatomyositis [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 jul. 03 ] Available from: https://doi.org/10.1186/s42358-018-0018-8
Vancouver
Silva TCP da, SILVA MG, Shinjo SK. Relevance of serum angiogenic cytokines in adult patients with dermatomyositis [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 jul. 03 ] Available from: https://doi.org/10.1186/s42358-018-0018-8

Unidades USP

ReP

Filtros

Autores

Assuntos